Clinical trial · Interventional
Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
Effect of Sukshma Vyayama Joint Loosening Yoga on Aromatase Inhibitor-Induced Arthralgia in Post-Menopausal Breast Cancer Survivors: A Feasibility Study Conducted on Facebook
NCT04042870CI-TRIAL-00039859completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the efficacy of sukshma vyayama joint loosening yoga in improving aromatase inhibitor-induced arthralgia in post-menopausal breast cancer survivors and secondarily, to evaluate the feasibility of delivering the intervention on Facebook.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Joint Loosening Yoga | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Joint Loosening Yoga
- description
- Yoga Intervention. Dose: 15 minutes, M-F for 4-weeks.
- interventionNames
- Behavioral: Joint Loosening Yoga
Primary outcomes (5)
- measure
- Change in Patient-Reported Arthralgia Inventory (PRAI) Measure for Joint Arthralgia
- timeFrame
- Baseline and Four weeks
- description
- The Patient-Reported Arthralgia Inventory measures self-reported pain intensity in 16 specific joints over the past 7 days. This questionnaire consists of 16 questions answered on a 0 to 10 scale (0 = no pain at all; 10 = worst pain you can imagine) with a min of 0 and a max of 160. Higher scores indicate more pain.
- measure
- Change in Brief Pain Inventory Short Form (BPI SF) Measure for Body Pain
- timeFrame
- Baseline and Four weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 35 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Postmenopausal breast cancer survivors undergoing treatment with aromatase inhibitor hormonal therapy with self-reported arthralgia * Must have initiated anastrazole, exemestane, or letrozole within 30 days of baseline assessment * 35-70 years old * Must be available during the dates of the study and willing to participate in the study * Must have access to computer, tablet or smart phone and Internet connection * Must be a member of Facebook * Eligible if their arthralgia started after initiation of an AI or if they had preexisting joint pain that was exacerbated by AI use * English speaking Exclusion Criteria: * Non English-speaking * Physically unable to perform the intervention
References
Publications (1)
- RESULTLeibel L, Metri K, Prasad R, Mears JG, Effect of Sukshma Vyayama on Aromatase Inhibitor-Induced Arthralgia in Post-Menopausal Breast Cancer Survivors: A Feasibility Study Conducted on Facebook, J Clin Oncol 37, 2019 (suppl; abstr e23129)